The Summary
Researchers conducted a meta-analysis of 64 randomized clinical trials to see if the effects of GLP-1 receptor agonists varied by patient demographics. Analyzing data from tens of thousands of participants, they found women lost an average of 10.9 percent of their body mass, compared to 6.8 percent for men. However, the medications' effectiveness was remarkably consistent across other factors, showing no significant differences based on age, race, ethnicity, starting size, or baseline blood sugar levels.
Why this is interesting
While it is widely known that GLP-1 medications are highly effective, doctors were not sure if they worked better for certain types of patients. This study shows that while these drugs are universally powerful tools regardless of age, race, or starting size, women experience significantly greater results than men. If you are considering these medications, this helps set realistic expectations: women might see dramatic percentage drops, while men can still expect great results, but may naturally see a slightly smaller percentage reduction.